Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 17/20 | 0.60 |
| ▸ | AR | P10275 | 4/20 | 0.44 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL80297 | 0.86 | PGR (0.60) | PGRARNR3C2 | |
| Tanaproget SCHEMBL62188 | 0.75 | PGR (1.00) | PGR | |
| SCHEMBL14989874 | 0.73 | PGR (0.65) | PGRARNR3C2 | |
| SCHEMBL6429982 | 0.73 | PGR (0.62) | PGR | |
| SCHEMBL5519179 | 0.72 | PGR (0.76) | PGRARNR3C2 | |
| SCHEMBL13579113 | 0.71 | PGR (0.77) | PGRARNR3C2 | |
| SCHEMBL5512567 | 0.70 | PGR (0.74) | PGRARNR3C2 | |
| SCHEMBL4471074 | 0.70 | PGR (0.51) | PGRAR | |
| SCHEMBL4491897 | 0.70 | PGR (0.49) | PGRAR | |
| SCHEMBL80296 | 0.70 | PGR (0.57) | PGRARNR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129524-B2 | Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same | WYETH LLC (US) | 2012-03-06 | — | — | US | claimed |
| US-20120016118-A1 | CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME | WYETH LLC (US) | 2012-01-19 | — | — | US | claimed |
| US-8003784-B2 | Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same | WYETH LLC (US) | 2011-08-23 | — | — | US | claimed |
| US-20090306371-A1 | CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME | WYETH (US) | 2009-12-10 | — | — | US | claimed |
| US-7582755-B2 | Such as 2-amino-5-(5-cyano-1-methyl-1H-pyrrol-2-yl) benzoic acid methyl ester by reacting cyanopyrrole with coupling agent, reacting with anthranilic alcohol or anthranilic nitro alcohol to form cyanopyrrole substituted anthranilic alcohol or cyanopyrrole substituted anthranilic nitro alcohol, reducing | WYETH (US) | 2009-09-01 | — | — | US | claimed |
| EP-1756095-B1 | CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME | WYETH CORP (US) | 2008-05-21 | — | — | EP | claimed |
| EP-1175411-B1 | CYCLOTHIOCARBAMATE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS | WYETH CORP (US) | 2008-02-20 | — | — | EP | claimed |
| US-20050239779-A1 | Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same | WYETH (US) | 2005-10-27 | — | — | US | claimed |
| US-8168672-B2 | Thioamide derivatives as progesterone receptor modulators | WYETH (US) | 2012-05-01 | — | — | US | disclosed |
| US-8129524-B2 | Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same | WYETH LLC (US) | 2012-03-06 | — | — | US | disclosed |
| US-20120016118-A1 | CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME | WYETH LLC (US) | 2012-01-19 | — | — | US | disclosed |
| US-8003784-B2 | Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same | WYETH LLC (US) | 2011-08-23 | — | — | US | disclosed |
| US-7659265-B2 | Thioamide derivatives as progesterone receptor modulators | WYETH (US) | 2010-02-09 | — | — | US | disclosed |
| US-20090306371-A1 | CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME | WYETH (US) | 2009-12-10 | — | — | US | disclosed |
| EP-1732921-A1 | THIOAMIDE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS | Wyeth (US) | 2006-12-20 | — | — | EP | disclosed |
| EP-1732922-A1 | METHODS FOR MINIMIZING THIOAMIDE IMPURITIES | Wyeth (US) | 2006-12-20 | — | — | EP | disclosed |
| WO-2005100346-A1 | THIOAMIDE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS | WYETH (US) | 2005-10-27 | — | — | WO | disclosed |
| US-20050239779-A1 | Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same | WYETH (US) | 2005-10-27 | — | — | US | disclosed |
| WO-2005100347-A1 | METHODS FOR MINIMIZING THIOAMIDE IMPURITIES | WYETH (US) | 2005-10-27 | — | — | WO | disclosed |
| US-20050228179-A1 | Methods for minimizing thioamide impurities | WYETH (US) | 2005-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239779-A1 | Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same | CBR3, MMAB, CTH | PGR 1697/4885AR 1796/4885NR3C2 1141/4885 |
| US-20050228179-A1 | Methods for minimizing thioamide impurities | TST, TXN, TTR | PGR 3997/4885AR 1924/4885NR3C2 690/4885 |
| US-20120016118-A1 | CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME | CBR3, CTH, MMAB | PGR 2282/4885AR 1929/4885NR3C2 1420/4885 |
| US-20090306371-A1 | CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME | CBR3, CTH, MMAB | PGR 2293/4885AR 1991/4885NR3C2 1417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.